Last $156.95 USD
Change Today +0.28 / 0.18%
Volume 2.8M
SLXP On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitleKey Developments
Thomas D'Alonzo Esq., J.D. 42 RelationshipsChairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation CommitteeSalix Pharmaceuticals Ltd. Announces Restatement of Consolidated Financial Statements for the Full Year 2013 and the First Three Quarters and Nine Months of 2014
01/28/15
John Chappell 7 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee 
Mark Sirgo Pharm.D. 20 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit Committee 
William Keane M.B.A. 4 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee 

Compensation Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitle
John Chappell 7 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Thomas D'Alonzo Esq., J.D. 42 RelationshipsChairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
William Keane M.B.A. 4 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Mark Sirgo Pharm.D. 20 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit Committee
Key PositionIndustry Range
No Compensation vs Industry data is available for SLXP.
52 Week Price Performance
Share price activity for SALIX PHARMACEUTICALS LTD (SLXP)
SLXP
Industry Average

Nominating Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitleKey Developments
Thomas D'Alonzo Esq., J.D. 42 RelationshipsChairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation CommitteeSalix Pharmaceuticals Ltd. Announces Executive Changes
02/5/15
John Chappell 7 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation CommitteeSalix Pharmaceuticals Promotes William P. Forbes to President, Medical, R&D and Chief Development Officer
02/2/15
Mark Sirgo Pharm.D. 20 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit CommitteeSalix Pharmaceuticals, Ltd. Announces Management Changes
01/5/15
William Keane M.B.A. 4 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation CommitteeSalix Pharmaceuticals, Ltd. Announces Executive Changes
11/6/14

Corporate Governance Committee* - salix pharmaceuticals ltd (SLXP)

Name (Connections)Board RelationshipsTitle
John Chappell 7 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
Thomas D'Alonzo Esq., J.D. 42 RelationshipsChairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
William Keane M.B.A. 4 RelationshipsDirector, Chairman of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Mark Sirgo Pharm.D. 20 RelationshipsDirector, Chairman of Compensation Committee, Member of Nominating/Corporate Governance Committee and Member of Audit Committee
SLXP and Competitor
Insiders vs. External
Board
25%
75%
Salix Pharmaceuticals Ltd.
25%
75%
Alkermes plc
0%
100%
Akorn, Inc.
23%
77%
Recordati SpA
9%
91%
Jazz Pharmaceuticals Public Limited Company
40%
60%
Lupin Limited
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SLXP:US $156.95 USD +0.28

SLXP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $53.47 USD +7.07
Alkermes PLC $71.23 USD +0.12
Jazz Pharmaceuticals PLC $175.19 USD -3.91
Lupin Ltd 1,738 INR +39.95
Recordati SpA €16.20 EUR -0.06
View Industry Companies
 

Industry Analysis

SLXP

Industry Average

Valuation SLXP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.2x
Price/Book 18.9x
Price/Cash Flow 100.7x
TEV/Sales 4.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SALIX PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.